Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients

CONCLUSION: Nirmatrelvir-ritonavir treatment significantly reduced oxygen therapy requirements in high-risk patients with COVID-19 during the omicron variant surge in South Korea. Physicians are encouraged to consider the active use of nirmatrelvir-ritonavir and to be watchful for gastrointestinal symptoms during medication.PMID:37667578 | PMC:PMC10477076 | DOI:10.3346/jkms.2023.38.e272

Source: J Korean Med Sci - September 5, 2023 Category: General Medicine Authors: Min-Kyung Kim Kyung-Shin Lee Sin Young Ham Youn Young Choi Eunyoung Lee Seungjae Lee Bora Lee Jaehyun Jeon BumSik Chin Yeonjae Kim Gayeon Kim Hee-Chang Jang Jae-Phil Choi Sang-Won Park Source Type: research